Literature DB >> 21958081

The association of specific metabolites of lipid metabolism with markers of oxidative stress, inflammation and arterial stiffness in men with newly diagnosed type 2 diabetes.

Chang Young Ha1, Ji Young Kim, Jean Kyung Paik, Oh Yoen Kim, Yong-Han Paik, Eun Jig Lee, Jong Ho Lee.   

Abstract

OBJECTIVE: To determine whether circulating metabolic intermediates are associated with inflammation, oxidative stress and arterial stiffness in men with newly diagnosed type 2 diabetes and investigate the circulating metabolic intermediates that may predict the risk of developing diabetes. RESEARCH DESIGN AND METHODS: Men with newly diagnosed type 2 diabetes (n = 26) and age- and body mass index-matched nondiabetic men (n = 27) were included. We measured inflammatory and oxidative markers and arterial stiffness by brachial-ankle pulse wave velocity (ba-PWV). Metabolomic profiling was analysed with ultra performance liquid chromatography and quadrupole time-of-flight mass spectrometry.
RESULTS: Diabetic men showed higher circulating levels of glucose, triglyceride, oxidized low-density lipoprotein (LDL), high-sensitivity C-reactive protein, interleukin (IL)-6, tumour necrosis factor-alpha (TNF-α), homeostasis model assessment-insulin resistance, urinary 8-epi-prostaglandin F(2α) (8-epi-PGF(2α)) and ba-PWV than nondiabetic men. In plasma, 19 metabolites including three amino acids, eight acylcarnitines, six lysophosphatidylcholines (lysoPCs), and two lysophosphatidylethanolamines (lysoPEs; C18:2 and C22:6) significantly increased in diabetes men, whereas serine and lysoPE (C18:1) decreased. Decanoyl carnitine, lysoPCs (C14:0, C16:1, C18:1 and C22:6) and lysoPE (C18:1) with variable importance in the projection values >1·0 were major plasma metabolites that distinguished nondiabetic and diabetic men. Decanoyl carnitine positively correlated with oxidized LDL, 8-epi-PGF(2α), IL-6, TNF-α and ba-PWV. ba-PWV correlated positively with lysoPCs C14:0 and C16:1, and negatively with lysoPE C18:1. 8-epi-PGF(2α) correlated positively with lipoprotein-associated phospholipase A(2), ba-PWV and lysoPCs (C14:0 and C16:1). The receiver operating characteristic curve estimation suggested that decanoyl carnitine and lysoPC (C14:0) are the best metabolites for predicting the risk of developing diabetes.
CONCLUSIONS: Circulating lipid-related intermediate metabolites can be closely associated with inflammation, oxidative stress and arterial stiffness in early diabetes.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21958081     DOI: 10.1111/j.1365-2265.2011.04244.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  54 in total

Review 1.  Overview of genomics and post-genomics research on type 2 diabetes mellitus: Future perspectives and a framework for further studies.

Authors:  Battini Mohan Reddy; Rayabarapu Pranavchand; S A A Latheef
Journal:  J Biosci       Date:  2019-03       Impact factor: 1.826

Review 2.  Metabolomics in human type 2 diabetes research.

Authors:  Jingyi Lu; Guoxiang Xie; Weiping Jia; Wei Jia
Journal:  Front Med       Date:  2013-02-02       Impact factor: 4.592

3.  Association between urinary 8-OHdG and pulse wave velocity in hypertensive patients with type 2 diabetes mellitus.

Authors:  Kazuhiko Kotani; Toshiyuki Yamada
Journal:  Singapore Med J       Date:  2014-04       Impact factor: 1.858

4.  Metabolites as novel biomarkers for childhood obesity-related traits in Mexican-American children.

Authors:  V S Farook; L Reddivari; G Chittoor; S Puppala; R Arya; S P Fowler; K J Hunt; J E Curran; A G Comuzzie; D M Lehman; C P Jenkinson; J L Lynch; R A DeFronzo; J Blangero; D E Hale; R Duggirala; J Vanamala
Journal:  Pediatr Obes       Date:  2014-11-18       Impact factor: 4.000

5.  Replacing with whole grains and legumes reduces Lp-PLA2 activities in plasma and PBMCs in patients with prediabetes or T2D.

Authors:  Minjoo Kim; Se Ri Jeung; Tae-Sook Jeong; Sang-Hyun Lee; Jong Ho Lee
Journal:  J Lipid Res       Date:  2014-06-05       Impact factor: 5.922

6.  Metabolic master regulators: sharing information among multiple systems.

Authors:  Barbara E Corkey; Orian Shirihai
Journal:  Trends Endocrinol Metab       Date:  2012-08-30       Impact factor: 12.015

7.  Metabolomic identification of diagnostic serum-based biomarkers for advanced stage melanoma.

Authors:  A W L Bayci; D A Baker; A E Somerset; O Turkoglu; Z Hothem; R E Callahan; R Mandal; B Han; T Bjorndahl; D Wishart; R Bahado-Singh; S F Graham; R Keidan
Journal:  Metabolomics       Date:  2018-08-03       Impact factor: 4.290

Review 8.  Metabolomics in Prediabetes and Diabetes: A Systematic Review and Meta-analysis.

Authors:  Marta Guasch-Ferré; Adela Hruby; Estefanía Toledo; Clary B Clish; Miguel A Martínez-González; Jordi Salas-Salvadó; Frank B Hu
Journal:  Diabetes Care       Date:  2016-05       Impact factor: 19.112

Review 9.  Acylcarnitines--old actors auditioning for new roles in metabolic physiology.

Authors:  Colin S McCoin; Trina A Knotts; Sean H Adams
Journal:  Nat Rev Endocrinol       Date:  2015-08-25       Impact factor: 43.330

10.  Branched chain amino acids are associated with muscle mass in functionally limited older adults.

Authors:  Michael S Lustgarten; Lori Lyn Price; Angela Chale; Edward M Phillips; Roger A Fielding
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-10-01       Impact factor: 6.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.